Binkui Li

11PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 25, 2024
m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma.

Zhu Lin, Zhenkun Huang, Jiliang Qiu

|Dec 14, 2023
RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1.

Zhiyu Qiu, Chenwei Wang, Pinzhu Huang

|Apr 06, 2023
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.

Yunxing Shi, Yi Niu, Yichuan Yuan

|Aug 30, 2022
S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.

Chengrui Zhong, Yi Niu, Wenwu Liu

|Aug 04, 2022
NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3.

Yuanping Zhang, Dinglan Zuo, Jiliang Qiu

Pageof 2